Month: August 2018

Snippet : Migraine


Teva’s migraine drug is expected to launch this year despite the delay in FDA approval Teva Pharmaceutical’s fremanezumab for treating...

Read More


Notizia, Pharma Consultant, The Business Cocktail

Progenics got FDA Approval on Iobenguane I 131 for Rare Adrenal Gland Tumors  A good news for unresectable rare adrenal tumor  patients...

Read More

Business Cocktail

Business Consultant, Pharma Consultant, The Business Cocktail

Sutro Biopharma nets $85.4M to drive antibody-drug conjugates Sutro Biopharma reeled in an $85.4 million series E that will advance some...

Read More

Snippets : Parkinson

Business Consultant, Pharma Consultant, Snippets

‘Reprogrammed’ stem cells to be tested in people with Parkinson’s Doctors in Japan are poised to implant neural cells made from...

Read More